AHL
LENZ

Abel Hall LLC’s LENZ Therapeutics LENZ Stock Holding History

Abel Hall LLC’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.2K Buy
+15,876
New +$128K 0.02% 851

Other funds holding LENZ

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Abel Hall LLC's LENZ Position: Q2 2026 in Review

Abel Hall LLC opened a new position in LENZ Therapeutics (LENZ) in Q2 2026: 15,876 shares worth $90.2K. The stake represents 0.02% of the portfolio and ranks #851 among its holdings.

20 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • Abel Hall LLC held 15,876 shares of LENZ Therapeutics worth $90.2K as of Q2 2026.
  • LENZ Therapeutics was a new Abel Hall LLC position in Q2 2026.
  • LENZ Therapeutics made up 0.02% of Abel Hall LLC's portfolio in Q2 2026, its #851 holding.
  • 20 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.